JWCA
TMDX icon

J.W. Cole Advisors’s Transmedics TMDX Stock Holding History

J.W. Cole Advisors’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-12,384
Closed -$772K – 1347
2024
Q4 		$772K Buy
12,384
+2,127
+21% +$198K 0.03% 490
2024
Q3 		$1.61M Sell
10,257
-4,048
-28% -$624K 0.07% 290
2024
Q2 		$2.15M Buy
+14,305
New +$1.72M 0.1% 203
2024
Q1 		– Sell
-6,526
Closed -$515K – 921
2023
Q4 		$515K Sell
6,526
-10,449
-62% -$630K 0.03% 477
2023
Q3 		$929K Buy
+16,975
New +$1.22M 0.07% 272
2023
Q2 		– Sell
-5,130
Closed -$388K – 818
2023
Q1 		$388K Buy
+5,130
New +$355K 0.03% 515

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

J.W. Cole Advisors's TMDX Position: Q1 2025 in Review

J.W. Cole Advisors sold out of Transmedics (TMDX) in Q1 2025, closing a stake of 12,384 shares — an estimated $772K sold.

J.W. Cole Advisors first reported a position in TMDX in Q1 2023 and held it in 6 quarters. The position peaked at $2.15M in Q2 2024. 298 funds tracked by Wall St. Rank hold TMDX as of Q1 2025.

  • J.W. Cole Advisors reported no remaining Transmedics position as of Q1 2025 after selling out during the quarter.
  • J.W. Cole Advisors sold 12,384 Transmedics shares in Q1 2025, an estimated $772K.
  • J.W. Cole Advisors first reported a position in Transmedics in Q1 2023 and held it in 6 quarters.
  • J.W. Cole Advisors's Transmedics position peaked at $2.15M in Q2 2024.
  • 298 funds tracked by Wall St. Rank held Transmedics as of Q1 2025.

Based on J.W. Cole Advisors's 13F filing for Q1 2025, filed 5 May 2025.